Denver, CO (PRWEB) December 1, 2008
LegalView, the number one site for everything and anything legal on the Web, recently alerted mesothelioma information blog readers of a scientific discovery involving two genes found on the fifth chromosome. The genes may be responsible for why certain individuals develop specific types of lung cancers such as mesothelioma cancer, according to a recent article published in the science journal Nature Genetics. Researchers from the World Health Organization's (WHO) International Agency for Research on Cancer identified the genes, TERT and CRR9, as responsible for a potential 60 percent increased risk of developing certain types of lung cancer in patients. Identifying the genes will likely assist in the development of improved lung cancer treatments, according to WHO researchers.
Mesothelioma is a type of lung cancer that develops when defects in strands of DNA occur. When asbestos fibers are inhaled into the lungs they begin to cause the creation of cancerous cells, or defects in the DNA, on the mesothelium, or lining of the organs. It often takes years before this deadly lung cancer reveals itself and the condition often remains dormant for 20 to 30 years. By the time it is revealed, it is often untreatable and life expectancy is, on average, 12 months from the diagnosis of mesothelioma.
Individuals who suffer from mesothelioma often carry the TERT and CRR9 genes and are often considered more likely to develop pleural mesothelioma. Those who have been affected by mesothelioma should consider consulting with a knowledgeable mesothelioma lawyer on the details of a potential mesothelioma lawsuit. Developing litigation with an experienced mesothelioma law firm may provide a return of monetary compensation, which will assist in paying pricey medical bills.
For more information on mesothelioma news and treatments individuals can use the LegalView legal library, which enables access to a wide array of legal topics such as the Ketek controversy, as well as information on truck accidents and the rare illness known as Nephrogenic Systemic Fibrosis (NSF).
The prescription drug Ketek is often prescribed to patients who are suffering from upper respiratory infections including community acquired pneumonia and bronchitis. The antibiotic, however, has been allegedly associated with causing liver damage among patients and has been investigated by the U.S. Food and Drug Administration (FDA) who have not removed the drug from the market. However, Ketek patients who may have been negatively affected by any Ketek side effects are advised to consult a physician immediately as well as speak to a pharmaceutical attorney regarding the drug's alleged dangers.
LegalView's truck accident information portal provides continually updated news articles and information on truck accident lawsuits as well as what to do if involved in a heavy truck collision, which is considered one of the most costly and most fatal vehicular accidents that can occur.
Nephrogenic Systemic Fibrosis is similar to mesothelioma in that both are rare conditions that can be extremely painful and debilitating. The cause of NSF is currently unknown, but the condition has been strongly linked to the use of gadolinium contrast dyes during magnetic resonance imaging and magnetic resonance angiography (MRI/MRA) tests among kidney disease patients. The NSF symptoms can include swelling and thickening of the skin, developing large scabs/wounds on the skin, and the paralyzation of limbs due to swelling and thickening of skin around the joints. For more information on NSF, visit http://www.LegalView.com/ .
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.LegalView.com.